This is a discussion on FDA issues an updated Early Communication about an Ongoing Safety Review of Tiotropium (marketed as Spiriva HandiHaler). within the FDA News forum, part of the Industry News and Updates category; FDA issues an updated Early Communication about an Ongoing Safety Review of Tiotropium (marketed as Spiriva HandiHaler). More......
|
|||||||
| Register | Help | Members List | Mark Forums Read |
|
|||
|
FDA issues an updated Early Communication about an Ongoing Safety Review of Tiotropium (marketed as Spiriva HandiHaler).
More... |
![]() |
| Thread Tools | |
| Display Modes | |
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Epoetin alfa - Early Communication about an Ongoing Safety Review | industry_news | FDA News | 0 | 09-26-2008 12:42 PM |
| FDA issues an Early Communication About an Ongoing Safety Review of Vytorin, Zocor, and Zetia. | industry_news | FDA News | 0 | 08-22-2008 03:44 PM |
| FDA issues an Early Communication About an Ongoing Safety Review of Tumor Necrosis Factor (TNF) Blockers (marketed as Re | industry_news | FDA News | 0 | 06-07-2008 07:30 PM |
| FDA issues an Early Communication about an Ongoing Safety Review for Botox | industry_news | FDA News | 0 | 02-26-2008 03:30 PM |
| FDA Issues Early Communication about an Ongoing Review of Vytorin | industry_news | FDA News | 0 | 02-26-2008 03:30 PM |